Cross-Protection against Acute

Patricia García, Maria P Cabral, Alejandro Beceiro, Miriam Moscoso, Germán Bou

Open access · goldAbstract read

In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.4field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

Screening and Identification of Natural Compounds as Potential Inhibitors of Glutamate Racemase, an Emerging Drug Target of Food PathogenInfectious disorders drug targets · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patricia GarcíaDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0002-0418-296X

Maria P CabralDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0002-7119-440X

Alejandro BeceiroDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.

Miriam MoscosoDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0001-8977-3269

Germán BouDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0001-8837-0062

Instituto de Salud Carlos III · ESComplexo Hospitalario Universitario A Coruña · ES

Funding

Axencia Galega de Innovacion IN607D 2021/12CIBERINFECT no grant numberInstituto de Salud Carlos III PI15/00860, PI18/00501, PI20/01212Red Espanola de Investigacion en Patologia Infecciosa RD12/0015/0014, RD16/0016/0006SERGAS-Galician Healthcare Service Program Innova Saúde

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute lung infection modelauxotrophicD-amino acid transaminase geneglutamate racemase geneintranasal immunizationlive-attenuated vaccineStaphylococcus aureus

Identifiers

PMID36851088

DOI10.3390/vaccines11020210

PMCPMC9963018

OpenAlexW4317393553

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.